The global liquid biopsy market in 2021 stood at US$1.28 billion, and is likely to reach US$3.93 billion by 2027. A liquid biopsy involves testing a sample of blood to see whether there are any cancer cells from a tumor that are circulating there or if there are any DNA fragments from tumor cells that are there. A liquid biopsy may be used to aid in the early detection of cancer.

The liquid biopsy has recently been driven by the rising incidence of cancer and the rising preference for fast, minimally invasive diagnostic testing. The liquid biopsy test is performed either on DNA isolated from tumor cells or on a blood sample to detect cancer cells existing in the blood stream. The government takes a number of steps to promote early cancer identification. The global liquid biopsy market is projected to grow at a CAGR of 20.4% during the forecast period of 2022-2027.

Scope of the Report

The report titled “Global Liquid Biopsy Market: Analysis By Product & Services (Kits & Reagents, Platforms & Instruments and Services), By Circulating Biomarker (Circulating Tumor Cell, CT-DNA, Extracellular Vesicles, and Others), By End-User (Hospitals & Laboratories, and Government & Academic Research Centers), By Application (Cancer, and Non Cancer) By Region Size and Trends with Impact of COVID-19 and Forecast up to 2027”, includes:

-- An in-depth analysis of the global liquid biopsy market by value, by product & services, by circulating biomarker, by end-user, by application, by region, etc.

-- The regional analysis of the liquid biopsy market includes the following regions:

North America (the US, Canada, and Mexico)
Europe (Germany, France, UK, and Rest of Europe)
Asia Pacific (Japan, China, India, South Korea, and Rest of the Asia Pacific)
Rest of the world

-- Comprehensive information about emerging markets. This report analyses the market for various segments across geographies.

-- Provides an analysis of the COVID-19 impact on the global liquid biopsy market, with post COVID impact analysis.

-- Assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall liquid biopsy market has also been forecasted for the period 2022-2027, taking into consideration the previous growth patterns, the growth drivers, and the current and future trends.

-- Evaluation of the potential role of liquid biopsy services to improve the market status.

-- Identification of new technological developments, R&D activities, and collaborations occurring in the liquid biopsy market.

-- In-depth profiling of the key players, including the assessment of the business overview, market strategies, regional and business segments of the leading players in the market.

-- The recent developments, mergers and acquisitions related to mentioned key players are provided in the market report.

-- The in-depth analysis provides an insight into the market, underlining the growth rate and opportunities offered in the business.

For further details, kindly visit :

https://www.daedal-research.com/pharma-healthcare/global-liquid-biopsy-market-size-and-trends-with-impact-of-covid-19-and-forecast-up-to-2027

Rajeev Kumar
(Business Development Manager)
Address: 36 SFS Flats
Paschim Vihar
New Delhi-110063
Mobile: +91-9811715635
Tel: +91-120-4553017
Mail ID - [email protected]